Medicare Enrolled
Dr. Lawrence Coskey, M.D.
Critical Care Medicine · Burlingame, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Coskey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Coskey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Coskey
Dr. Lawrence Coskey is a critical care medicine specialist in Burlingame, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Coskey performed 1,377 Medicare services across 980 unique beneficiaries.
Between the years covered by Open Payments, Dr. Coskey received a total of $6,937 from 39 pharmaceutical and/or device companies across 321 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Coskey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 23% volume in CA
$6,937 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,377
Medicare services
Top 23% in CA for critical care medicine
980
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~69 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
331 | $112 | $317 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
275 | $73 | $221 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
213 | $190 | $650 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
150 | $108 | $265 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
57 | $27 | $100 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
46 | $8 | $50 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
45 | $11 | $50 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
45 | $72 | $175 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
34 | $158 | $525 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
26 | $9 | $65 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
25 | $21 | $50 |
| New patient office visit, complex (60-74 min) | 21 | $201 | $516 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
19 | $11 | $100 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
16 | $195 | $494 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
14 | $95 | $290 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
14 | $73 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $158 | $392 |
| Bronchoscopy A diagnostic exam of the lung airways using an endoscope to visually inspect the inside of the lungs and airways. |
11 | $116 | $700 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
11 | $70 | $73 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
11 | $37 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,937
Total received (2018-2024)
Avg $991/year across 7 years
Top 17% in CA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
321
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,937 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$989
2023
$1,090
2022
$457
2021
$265
2020
$497
2019
$1,304
2018
$2,335
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$152
Boehringer Ingelheim Pharmaceuticals, Inc.
$136
GlaxoSmithKline, LLC.
$109
Amgen Inc.
$108
Actelion Pharmaceuticals US, Inc.
$98
GENZYME CORPORATION
$72
Insmed, Inc.
$60
Inari Medical, Inc.
$60
United Therapeutics Corporation
$34
Grifols USA, LLC
$31
Takeda Pharmaceuticals U.S.A., Inc.
$28
Novartis Pharmaceuticals Corporation
$27
Baxter Healthcare
$25
Regeneron Healthcare Solutions, Inc.
$24
PFIZER INC.
$22
Top 3 companies account for 40.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,699
Boehringer Ingelheim Pharmaceuticals, Inc.
$990
AstraZeneca Pharmaceuticals LP
$791
Insmed, Inc.
$482
Genentech USA, Inc.
$274
Electromed, Inc.
$249
Actelion Pharmaceuticals US, Inc.
$225
Gilead Sciences, Inc.
$179
Mylan Specialty L.P.
$171
Inari Medical, Inc.
$145
Sunovion Pharmaceuticals Inc.
$133
Janssen Pharmaceuticals, Inc
$130
GENZYME CORPORATION
$108
Amgen Inc.
$108
PFIZER INC.
$107
Grifols USA, LLC
$100
Merck Sharp & Dohme LLC
$98
PORTOLA PHARMACEUTICALS, INC.
$97
Teva Pharmaceuticals USA, Inc.
$89
Advanced Respiratory, Inc
$85
Takeda Pharmaceuticals U.S.A., Inc.
$77
Jazz Pharmaceuticals Inc.
$72
United Therapeutics Corporation
$62
Pulmonx Corporation
$59
Novartis Pharmaceuticals Corporation
$50
Intuitive Surgical, Inc.
$49
Baxter Healthcare
$48
JAZZ PHARMACEUTICALS INC.
$42
Mallinckrodt LLC
$35
Regeneron Healthcare Solutions, Inc.
$24
Astellas Pharma US Inc
$24
Resmed Corp
$22
Fisher & Paykel Healthcare Inc
$22
Allergan Inc.
$21
Merck Sharp & Dohme Corporation
$17
SANOFI PASTEUR INC.
$16
Bayer HealthCare Pharmaceuticals Inc.
$14
Circassia Pharmaceuticals Inc
$12
Chiesi USA, Inc.
$11
Top 3 companies account for 50.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADACEL · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · Arikayce · Astral · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · CARDENE · CHANTIX · CHARTIS CATHETER · CINQAIR · CRESEMBA · CUVITRU · DUPIXENT · Da Vinci Surgical System · ELIQUIS · Esbriet · FASENRA · FISHER & PAYKEL HEALTHCARE · FLOWTRIEVER CATHETER · FlowTriever · HYQVIA · Hillrom - Vest System Model 105 Home Care · KEYTRUDA · LONHALA MAGNAIR · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PNEUMOVAX 23 · Perforomist · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QVAR · S · SEEBRI · SHINGRIX · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON · Utibron · Vest 205 Metaneb System · XARELTO · XOLAIR · Xolair · Xyrem · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
114
Per 100K population
15.3
County median income
$156,000
Nearest hospital
PENINSULA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Coskey is a clinical cardiology specialist, with above-average Medicare volume (top 23% in CA), with low-engagement industry engagement in the top 17% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Coskey experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Coskey performed 331 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Coskey receive payments from pharmaceutical companies?
Yes. Dr. Coskey received a total of $6,937 from 39 companies across 321 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Coskey's costs compare to other critical care medicines in Burlingame?
Dr. Coskey's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Coskey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Burlingame
Browse critical care medicines in Burlingame ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in CA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in CA
Which CA critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology